optimal dapt choices for high-bleeding risk patients · esc 2014 esc/eacts guidelines on myocardial...

13
Optimal DAPT choices for high-bleeding risk patients A challenging patient with oral anticoagulant therapy Is there an alternative strategy? Christian Spaulding, MD, PhD, FACC, FESC Hôpital Européen Georges Pompidou, Paris, France

Upload: others

Post on 22-Jul-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Optimal DAPT choices for high-bleeding risk patients · ESC 2014 ESC/EACTS Guidelines on myocardial revascularization Windecker S et al, Eur Heart J. 2014;35:2541-619 Duration of

Optimal DAPT choices for high-bleeding risk patients

A challenging patient with oral anticoagulant therapyIs there an alternative strategy?

Christian Spaulding, MD, PhD, FACC, FESC

Hôpital Européen Georges Pompidou, Paris, France

Page 2: Optimal DAPT choices for high-bleeding risk patients · ESC 2014 ESC/EACTS Guidelines on myocardial revascularization Windecker S et al, Eur Heart J. 2014;35:2541-619 Duration of

Speaker's name: Christian Spaulding

I have the following potential conflicts of interest to report:

Receipt of honoraria or consultation fees:

• Abiomed, Zoll, Medtronic, Medpass, Astra-Zeneca, Cordis, Servier, Lead-Up, Bayer, the Medicines Company, Eli Lilly, WebMD.

Research grant from the French Ministry of Health

Potential conflicts of interest

Page 3: Optimal DAPT choices for high-bleeding risk patients · ESC 2014 ESC/EACTS Guidelines on myocardial revascularization Windecker S et al, Eur Heart J. 2014;35:2541-619 Duration of

The differences between French and Swiss

interventional cardiologists

Page 4: Optimal DAPT choices for high-bleeding risk patients · ESC 2014 ESC/EACTS Guidelines on myocardial revascularization Windecker S et al, Eur Heart J. 2014;35:2541-619 Duration of

Mr. JCA - 71 year old (born 1945)

Ad-hoc PCI or planned procedure ?Radial or femoral approach ?Which stent : DES or BMS?

Duration of DAPT?

Page 5: Optimal DAPT choices for high-bleeding risk patients · ESC 2014 ESC/EACTS Guidelines on myocardial revascularization Windecker S et al, Eur Heart J. 2014;35:2541-619 Duration of

Multidisciplinary approach

• The case clearly needs a consensus between the interventional cardiologist, the referring cardiologist, the surgeon and the anesthesiologist, and the patient !

Planned PCI procedure with pre-defined strategy after a consensus meeting

Page 6: Optimal DAPT choices for high-bleeding risk patients · ESC 2014 ESC/EACTS Guidelines on myocardial revascularization Windecker S et al, Eur Heart J. 2014;35:2541-619 Duration of

Meta-analysis of MACE in randomised studies comparing radial and femoral access for PCI

Hamon M et al, EuroIntervention 2013;8:1242-1251 MACE: major adverse cardiac eventsPCI: percutaneous coronary intervention

Radial approach if technically feasible by a trained operator

Page 7: Optimal DAPT choices for high-bleeding risk patients · ESC 2014 ESC/EACTS Guidelines on myocardial revascularization Windecker S et al, Eur Heart J. 2014;35:2541-619 Duration of

DES >>> BMS

Mehran R et al, Lancet 2013; 382: 1714–22

Page 8: Optimal DAPT choices for high-bleeding risk patients · ESC 2014 ESC/EACTS Guidelines on myocardial revascularization Windecker S et al, Eur Heart J. 2014;35:2541-619 Duration of

ESC 2014 ESC/EACTS Guidelines on myocardial revascularization

Windecker S et al, Eur Heart J. 2014;35:2541-619

Duration of DAPT ?

Page 9: Optimal DAPT choices for high-bleeding risk patients · ESC 2014 ESC/EACTS Guidelines on myocardial revascularization Windecker S et al, Eur Heart J. 2014;35:2541-619 Duration of

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

PCI: percutaneous coronary intervention, DAPT: dual antiplatelet therapy, DES: drug eluting stent, BMS: bare metal stent, mo: month, y: year

Levine GN et al, J Am Coll Cardiol, 2016

Page 10: Optimal DAPT choices for high-bleeding risk patients · ESC 2014 ESC/EACTS Guidelines on myocardial revascularization Windecker S et al, Eur Heart J. 2014;35:2541-619 Duration of

Joint consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or

undergoing percutaneous coronary or valve interventions

Lip YH et al, EHJ 2016

Page 11: Optimal DAPT choices for high-bleeding risk patients · ESC 2014 ESC/EACTS Guidelines on myocardial revascularization Windecker S et al, Eur Heart J. 2014;35:2541-619 Duration of

5.6

2.5

1.9

2.5

5.0

1.21.6

1.0 1.0

1.5

2.9

0.4

0

2

4

6

8

Any Death Cardiac Death TV related MI cd TLR TLF ST

%

OAC, N=160

Non-OAC, N=3411

P=0.002 P=0.09 P=0.22 P=0.31 P=0.18P=0.14

E-ULTIMASTER – Global registry

Clinical outcomes at 1 year

Page 12: Optimal DAPT choices for high-bleeding risk patients · ESC 2014 ESC/EACTS Guidelines on myocardial revascularization Windecker S et al, Eur Heart J. 2014;35:2541-619 Duration of

Patients on OAC

Different DAPT regiment

2.9 2.9

0.0

5.7 5.7

0.0

4.0 4.0

0.0

4.0 4.0

0.00.0 0.0

5.9 5.9 5.9

0.0

8.4

3.6

2.4

3.6

7.2

1.2

0

2

4

6

8

10

12

Death MI TLR TLF Bleeding ST

No DAPT at

Discharge +

Stopped <1m,

never resumed,

N°=35

No DAPT at

Discharge + Stopped

<1m, resumed DAPT

before 3m, N°=25

Stopped DAPT

between 1 and 3

months, N°=17

Continued DAPT

after 3 months,

N°=83

NS

%

Page 13: Optimal DAPT choices for high-bleeding risk patients · ESC 2014 ESC/EACTS Guidelines on myocardial revascularization Windecker S et al, Eur Heart J. 2014;35:2541-619 Duration of

An alternative strategy

• Planned PCI procedure after consensus meeting

• Radial approach

• DES

• Duration of DAPT and date of surgery:– According to the guidelines: 3 to 6 months

– One month ? : need for randomized data on DES and short duration of DAPT

• Randomize in MASTER DAPT !